Development of BCPDA-Eu3+-BAS labeled hepatitis B surface antibodies
Wenjia Tan , Zhixia Sun , Lili Xuan , Junling Li , Wenbing Xie , Chengyan He , Lihua Pan
Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (1) : 24 -27.
Development of BCPDA-Eu3+-BAS labeled hepatitis B surface antibodies
The effect of the chelating agent 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA) labeled hepatitis B surface antibodies(HBsAb) on time-resolved fluoroimmunoassays(TRFIA) was investigated. The labeling detection method was established. The biotin-streptavidin(BAS) system was introduced, and the multi-stage amplification effect of the BAS system was analyzed. It is found that the BCPDA-Eu3+-HBsAb-BAS fluorescent marker can emit strong fluorescence. Compared to BCPDA-Eu3+-HBsAb, BCPDA-Eu3+-HBsAb-BAS demonstrates an enhanced fluorescence intensity by over 10 times. This study provides a guidance for the next generation non-radio immunoassays in clinical diagnosis.
Time-resolved fluorescence immunoassay / Biotin / Streptavidin
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
/
| 〈 |
|
〉 |